A retrospective study to assess COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era
Latest Information Update: 14 Jul 2022
At a glance
- Drugs Nirmatrelvir+ritonavir (Primary) ; Sotrovimab (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 14 Jul 2022 New trial record
- 08 Jul 2022 Results published in the American Journal of Transplantation